About the Authors

Luis F. López-Cortés

lflopez@us.es

Affiliation Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Manuel A. Castaño

Affiliation Hospital Universitario Carlos Haya, Málaga, Spain

Miguel A. López-Ruz

Affiliation Hospital Universitario Virgen de las Nieves, Granada, Spain

María J. Rios-Villegas

Affiliation Hospital Universitario Virgen Macarena, Sevilla, Spain

José Hernández-Quero

Affiliation Hospital Universitario San Cecilio, Granada, Spain

Dolores Merino

Affiliation Complejo Hospitalario Juan Ramón Jiménez, Huelva, Spain

Patricia Jiménez-Aguilar

Affiliation Hospital Universitario de Puerto Real, Cádiz, Spain

Manuel Marquez-Solero

Affiliation Hospital Universitario Virgen de la Victoria, Málaga, Spain

Alberto Terrón-Pernía

Affiliation Hospital Jerez de la Frontera, Cádiz, Spain

Francisco Tellez-Pérez

Affiliation Hospital La Línea, Cádiz, Spain

Pompeyo Viciana

Affiliation Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Francisco Orihuela-Cañadas

Affiliation Hospital Universitario Carlos Haya, Málaga, Spain

Zaira Palacios-Baena

Affiliation Hospital Universitario Virgen Macarena, Sevilla, Spain

David Vinuesa-Garcia

Affiliation Hospital Universitario San Cecilio, Granada, Spain

Jose M. Fajardo-Pico

Affiliation Complejo Hospitalario Juan Ramón Jiménez, Huelva, Spain

Alberto Romero-Palacios

Affiliation Hospital Universitario de Puerto Real, Cádiz, Spain

Guillermo Ojeda-Burgos

Affiliation Hospital Universitario Virgen de la Victoria, Málaga, Spain

Juan Pasquau-Liaño

Affiliation Hospital Universitario Virgen de las Nieves, Granada, Spain

Competing Interests

FL and PV have received unrestricted grants for research and personal fees for speaking at symposia on behalf of Abbvie laboratories (Spain), Bristol-Myers Squibb, Glaxo Smithkline, Gilead Sciences, Janssen España, Merck Sharp & Dohme España, Roche Pharma SA, and ViiV Healthcare. MAL and MM have received unrestricted research grants and personal fees for speaking at symposia on behalf of Abbott laboratories (Spain), Janssen España, Merck Sharp & Dohme España, and ViiV Healthcare. JP has received unrestricted grants for research and speaker honoraria from Bristol-Myers Squibb, Janssen, Abbvie laboratories, Merck Sharp & Dohme, ViiV Healthcare, Gilead Sciences and Roche Pharma. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All other authors have no competing interests to declare.

Author Contributions

Conceived and designed the experiments: LFL. Performed the experiments: LFL MAC MAL MJR JH DM PJ MM AT FT PV FO ZP DV JMF AR GO JP. Analyzed the data: LFL. Contributed reagents/materials/analysis tools: LFL MAC MAL MJR JH DM PJ MM AT FT PV FO ZP DV JMF AR GO JP. Wrote the paper: LFL. Critical revision of the article for important intellectual content: JH DM JP.